Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00108290
Status:
COMPLETED
Last Update Posted:
2008-04-04
First Post:
2005-04-14
Brief Title:
Chemotherapy Hormone Therapy and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer
Sponsor:
US Department of Veterans Affairs
Organization:
VA Office of Research and Development
Study Overview
Official Title:
Chemohormone Therapy Prior to Prostatectomy in High Risk Prostate Cancer
Status:
COMPLETED
Status Verified Date:
2007-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In men with prostate cancer who do not have evidence of spread to bone or other sites on computed axial tomography CAT scanbone scan but are still at significant risk of failing treatment with surgery or radiation alone a combination of chemotherapy and hormone therapy is being given for 6 months followed by surgery to remove the prostate
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None